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Entamoeba histolytica trophozoites produce amoebapores, a family of small amphipathic peptides capable of
insertion into bacterial or eukaryotic membranes and causing cellular lysis. Recently, E. histolytica trophozoites
that are totally deﬁcient in the production of amoebapore-A were created through a gene silencing mechanism
(R. Bracha, Y. Nuchamowitz, and D. Mirelman, Eukaryot. Cell 2:295-305, 2003). Here we tested the virulence
of amoebapore A() trophozoites in models of the two major forms of amebic disease: amebic liver abscess and
amebic colitis. We demonstrate that amoebapore expression is required for full virulence in the SCID mouse
model of amebic liver abscess, but E. histolytica trophozoites that do not express amoebapore-A can still cause
inﬂammation and tissue damage in infected human colonic xenografts. These data are consistent with the con-
cept that tissue damage may proceed by different mechanisms in amebic liver abscess compared to amebic colitis.
One of the remarkable capacities of Entamoeba histolytica
trophozoites is their ability to lyse eukaryotic cells on contact.
This ability derives from amoebapores, a family of three pore-
forming peptides (amoebapore A [AP-A], AP-B, and AP-C)
(10, 12). Amoebapores insert into the membranes of bacteria
or eukaryotic cells and form pores that result in lysis of the
target cells. The addition of puriﬁed amoebapores to eukary-
otic cells results in cell necrosis and possibly apoptosis (2, 4,
11). E. histolytica trophozoites expressing decreased levels of
AP-A (by antisense inhibition) showed defects in cytolytic and
bactericidal functions (5). Trophozoites with decreased levels
of amoebapore were also less virulent in the hamster model of
amebic liver abscess, a ﬁnding consistent with a role for amoe-
bapores in liver abscess formation (5). Recently, it was found
that transfection of E. histolytica trophozoites with plasmid
psAP-1, a construct encoding the AP-A gene, ﬂanked by its
regulatory components or plasmid psAP-2, which contains only
470 bp of the 5 upstream ﬂanking region of the AP-A gene,
results in transcriptional silencing of the AP-A gene, with re-
sulting complete loss of AP-A expression (6). This complete
gene silencing contrasts with the residual amoebapore activity
seen when antisense inhibition was used, and the creation of
totally AP-A-deﬁcient E. histolytica trophozoites provides an
unprecedented opportunity to assess the role of AP-A in ame-
bic colitis and amebic liver abscess formation. Here, we exam-
ine the virulence of E. histolytica strain HM-1:IMSS trophozo-
ites lacking AP-A expression in two well-established models of
amebiasis: the severe combined immunodeﬁcient mouse-hu-
man intestinal xenograft (SCID-HU-INT) model of amebic
colitis and the SCID mouse model of amebic liver abscess.
MATERIALS AND METHODS
Strain and culture conditions. E. histolytica HM1:IMSS trophozoites were
grown at 37°C in TYI-S-33 media as previously described (14).
Plasmids and transfections. The pEhActNeo plasmid (1), which contains the
Neo gene conferring resistance to G418, the 5 and 3 untranslated regions from
the ameba actin 1 gene, and the E. histolytica autonomous replication sequence
served as the initial control vector for these experiments. Plasmid psAP-2 was
derived from pEhActNeo by inserting a fragment containing 470 bp of the
upstream 5 ﬂanking region of the ap-A gene (6). Trophozoites transfected with
the psAP-2 plasmid underwent selection with G418 to a maximum concentration
of 60 g/ml as previously described (6). After 2 months of selection, G418 was
withdrawn and, 60 days later, AP-A expression was assessed by real-time PCR
and immunoblotting. E. histolytica trophozoites used for liver challenges or
human colonic xenograft challenges had been grown without G418 for at least 90
days.
RNA preparation and real-time PCR. A total of 10
6 E. histolytica trophozoites
in log phase were harvested, washed twice by suspending them in cold phos-
phate-buffered saline (PBS), and centrifuged at 430  g for 5 min; the pellet was
suspended in TRIzol, and RNA was isolated according to the manufacturer’s
protocol (Invitrogen Life Technologies, Carslbad, Calif.). Reverse transcription
was performed with 2 g of total RNA, oligo(dT) as primers and avian myelo-
blastosis virus reverse transcriptase (Fisher Research, Pittsburg, Pa.). Primers for
PCR were designed by using Primer Express Software (Applied Biosystems,
Foster City, Calif.) and are shown in Table 1. Real-time PCR was carried out in
a total volume of 10 l with 200 nM primer pairs, 5 lo f2  SYBR Green PCR
Mastermix (Applied Biosystems), and various concentrations of cDNA template
under conditions of 50°C for 2 min and 95°C for 10 min, followed by 40 cycles
of 95°C for 15 s, followed by 60°C for 1 min by using a ABI 7700 (Applied
Biosystems). Each reaction was run in triplicate.
Immunoblotting. Soluble extracts from E. histolytica trophozoites that had
been previously transfected with psAP-2 or control E. histolytica trophozoites
were prepared as previously described (18), separated on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis under nonreducing conditions, transferred to
nitrocellulose membranes, and reacted with rabbit polyclonal antibodies against
AP-A (a gift of Matthias Leippe, University of Wurzburg, Wurzburg, Germany).
SCID mouse model of amebic liver abscess. BALB/c SCID mice, male, 6 to 8
weeks of age, were used for all experiments. For studies of amebic liver abscess,
10
6 AP-A() E. histolytica trophozoites or 10
6 trophozoites of the parent HM1:
IMSS E. histolytica strain were directly inoculated into the liver of SCID mice as
previously described (7). After 48 h, animals were sacriﬁced, and the livers were
removed and weighed. The abscessed region of the liver was cut out and weighed,
and the percent liver abscessed was calculated.
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678SCID-HU-INT mouse model of amebic colitis. Human colonic xenografts were
transplanted into the subscapular region of SCID mice (age, 6 to 8 weeks) and
allowed to mature for 8 weeks to generate SCID-HU-INT mice as previously
described (14). Log-phase cultures of E. histolytica HM1:IMSS AP-A()o rt h e
parental HM1:IMSS strain trophozoites were chilled on ice for 10 min, pelleted
by centrifugation at 500  g for 5 min, and resuspended in TYI-S-33 medium at
10
6 trophozoites/100 l. To establish amebic colitis, 100 l of the amebic sus-
pension was injected directly into the lumen of the grafts via a 26-gauge needle.
A small square of gelfoam was placed over the injection site upon removal of the
needle in order to prevent leakage. The incision was closed with 5-mm Michel
clips (14). At 24 h after inoculation, SCID-HU-INT mice were sacriﬁced, and
segments of the intestinal xenografts were assayed for cytokine and myeloper-
oxidase (MPO) production as previously described (15). Fifteen SCID-HU-INT
mice were used in each challenge group; 5 SCID-HU-INT mice served as the
uninfected controls.
Cytokine assays. Protein samples for enzyme-linked immunosorbent assay
(ELISA) were prepared by homogenizing tissue at 50 mg/ml in a solution of PBS
containing 1 g each of aprotinin, leupeptin, and pepstatin A (Sigma, St. Louis,
Mo.)/ml. The homogenized samples were centrifuged at 12,000  g for 15 min.
Supernatants were processed as speciﬁed by the suppliers of the ELISA kits.
ELISAs for interleukin-1 (IL-1) and IL-8 were obtained from Endogen
(Woburn, Mass.). The sensitivities were 1 pg/ml for IL-1 and 2 pg/ml for IL-8.
MPO assay. Tissue samples were homogenized for 30 s at a concentration of
50 mg/ml in a solution of PBS with 1 g each of aprotinin, leupeptin, and
pepstatin A/ml. Samples were spun at 12,000  g for 15 min, and the pellet was
resuspended in the same volume of 80 mM sodium phosphate–1% hexadecyl-
trimethylammonium bromide (Sigma)–5 mM EDTA (pH  5.4). Samples were
subjected three times to a freeze-thaw cycle and spun at 2,000  g for 15 min, and
the supernatants were used in the subsequent assay. Samples (25 l) were
combined with 125 l of 80 mM sodium phosphate (pH 5.4) and 25 l of 1.28
mM 3,3,5,5-tetramethylbenzidine dihydrochloride (Sigma) in dimethyl sulfox-
ide. A total of 25 lo fH 2O2 in 80 mM sodium phosphate was added immediately
prior to analysis to yield a ﬁnal concentration of 0.24 mM and a ﬁnal reaction
volume of 200 l. Conversion of the substrate was read at 650 nm. Dilutions of
puriﬁed MPO (Sigma) were used as standards.
Measurement of intestinal permeability. Dextrans of approximate mass of
4,000 Da labeled with ﬂuorescein isothiocyanate (FITC) were purchased from
Sigma and resuspended in endotoxin-free PBS at a concentration of 5 mg/ml. At
4 h prior to sacriﬁce, the renal pedicle was tied off to prevent excretion of the
ﬂuorophore, and 50 l of the solution was injected directly into the lumen of the
graft. At the time of sacriﬁce, animals were bled, and 20 l of blood was diluted
into 400 l of 150 mM NaCl–50 mM Tris (pH 10.3) and spun at 2,000  g for 15
min. The supernatants from this spin were analyzed on a Cytoﬂuor 23000 ﬂuo-
rescent plate reader (Millipore, Bedford, Mass.)
RESULTS
Reduction of AP-A expression in psAP-2-transfected E. his-
tolytica. We ﬁrst conﬁrmed that E. histolytica trophozoites that
had been transfected earlier with the psAP-2 plasmid had
undergone silencing of the ap-A gene (6). Real-time PCR was
performed on three different RNA samples obtained from
psAP-2-transfected E. histolytica trophozoites 3 months after
removal of G418 selection and from three different RNA sam-
ples obtained from the parental E. histolytica HM1:IMSS
strain. Primers speciﬁc for AP-A, AP-B, and AP-C were used,
along with primers for actin and E. histolytica 18S rRNA as
controls. The psAP-2-transfected trophozoites demonstrated a
5,000-fold decrease in AP-A expression compared to the
parental control trophozoites (Table 2). AP-B expression was
also signiﬁcantly decreased (400-fold), but we found no evi-
dence for a decrease of expression of AP-C. Transcripts for
actin and 18S RNA were present in roughly equivalent num-
bers in all samples. The results from the real-time PCR analysis
were conﬁrmed by immunoblotting with polyclonal antibodies
against puriﬁed AP-A. As shown in Fig. 1, lysates obtained
from AP-A() trophozoites showed little detectable AP-A
compared to lysates obtained from the parental E. histolytica
HM1:IMSS strain.
E. histolytica trophozoites lacking AP-A expression show re-
duced virulence in the SCID mouse model of amebic liver
abscess. When E. histolytica trophozoites are directly inocu-
lated into the livers of SCID mice, they cause liver abscesses,
which reach maximum size approximately 48 h after inocula-
tion (7, 19). We challenged groups of 13 SCID mice with
intrahepatic inoculations of 10
6 E. histolytica AP-A() tro-
phozoites or 10
6 trophozoites of the control, parental HM1:
IMSS strain and assessed liver abscess size at 48 h. As shown in
Fig. 2, E. histolytica trophozoites lacking AP-A caused signiﬁ-
cantly smaller liver abscesses than control HM1:IMSS tropho-
zoites (P 	 0.05 in a two-tailed t test comparing the mean
percentage of the liver occupied by abscess in each group) after
direct inoculation into the livers of SCID mice. Histologic
examination of microscopic sections of the amebic liver ab-
TABLE 1. Primers used for real-time PCR
Gene Forward primer sequence Reverse primer sequence
AP-A 5-CACTAAGGGAGCTGATAAAGTAAAAGATTA-3 5-TCCAAAATCAAGAACTTTAGTGCAA-3
AP-B 5-TGGTGCTCAAGCTGTTAGACAATAT-3 5-AAGGATTTTTTCACAAAGAGTTCCA-3
AP-C 5-TCCTGTTTGTACATCACTTGTTGGA-3 5-GCACAGAGTGTTTCAAGATAATCAGTTAC-3
Actin 5-TGTAGATAATGGATCAGGAATGTGTAAA-3 5-CAATGGATGGGAATACAGCTCTT-3
18S RNA 5-TGGTGCATGGCCGTTCTTA-3 5-AATTAATAGGTTTCAGTCTCGTTCGTT-3
TABLE 2. Real-time PCR analysis of amoebapore expression in
AP-A() E. histolytica trophozoites and the parental
E. histolytica HM1:IMSS strain
a
Gene Sample Mean Ct 
Ct 

Ct Fold difference
AP-A AP() 27.5 12.4
Control 15.2 0 12.4 5,404.704
AP-B AP() 23.6 8.5
Control 14.9 0.3 8.8 445.7219
AP-C AP()1 50.1
Control 14.8 0.4 0.3 1.231
18S rRNA AP() 15.1
Control 15.2
Values shown for mean threshold cycle (Ct) were obtained from three differ-
ent samples of RNA obtained from cultures of AP-A() E. histolytica tropho-
zoites [AP()] or the parental E. histolytica HM1:IMSS strain (control). The 
Ct
represents the difference in cycle time for the indicated gene between AP() and
control E. histolytica trophozoites; the 

Ct values were obtained by using the
values for 18S RNA as the internal control. Similar results were seen when actin
was used as the standard (data not shown). Relative quantiﬁcation of amoeba-
pore gene expression was performed using the comparative Ct method (Applied
Biosystems) by using the expression 2


Ct to calculate the fold difference in
transcript level.
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induced by AP-A() trophozoites and those induced by the
parental E. histolytica HM1:IMSS strain (data not shown).
E. histolytica trophozoites lacking AP-A show a mixed phe-
notype in the SCID-HU-INT model of amebic colitis. We next
examined whether amebic trophozoites lacking AP-A showed
altered virulence in the SCID-HU-INT model of amebic coli-
tis. The lumens of human colonic xenografts in SCID-HU-INT
mice were inoculated with 10
6 trophozoites of the parent HM1:
IMSS strain or 10
6 AP-A () E. histolytica trophozoites. E.
histolytica trophozoites induce the production of inﬂammatory
mediators, including interleukin-1 (IL-1) and IL-8, in hu-
man intestinal xenografts (14, 15, 20). The mean levels of
IL-1 and IL-8 from 15 human intestinal xenografts infected
with AP-A() E. histolytica trophozoites were signiﬁcantly
higher than the mean levels of IL-8 and IL-1 from ﬁve unin-
fected human intestinal xenografts (P 	 0.01 [two-tailed Stu-
dent t test]), but were signiﬁcantly lower (P 	 0.05 [two-tailed
Student t test]) than the mean levels obtained from 15 human
colonic xenografts infected with the parental HM1:IMSS strain
(Fig. 3A and B).
To measure inﬂammation in E. histolytica-infected human
intestinal xenografts, we measured the levels of MPO, a neu-
trophil/early monocyte-speciﬁc marker. MPO levels increase in
E. histolytica-infected xenografts, correlating with the degree of
neutrophil inﬂux, but are undetectable in uninfected xeno-
grafts (15). We found that the mean MPO levels were signif-
icantly higher in the human intestinal xenografts infected with
the parental E. histolytica HM1:IMSS strain or the E. histo-
lytica AP-A() trophozoites compared to uninfected xeno-
grafts (P 	 0.01 for each comparison by using a two-tailed
Student t test) (Fig. 3C). Although the levels of MPO were
lower in human colonic xenografts infected with AP-A()
E. histolytica trophozoites compared to the parental HM1:
IMSS strain, the difference did not reach statistical signiﬁcance
(P  0.46 [two-tailed Student t test]).
We also looked for differences in intestinal permeability
between human colonic xenografts infected with AP-A-deﬁ-
cient E. histolytica trophozoites or the parental HM1:IMSS
strain by introducing ﬂuoresceinated dextran (FITC-dex) into
the lumen of the human colonic xenografts and measuring its
levels in the serum of SCID-HU-INT mice 24 h later (15).
Wild-type E. histolytica trophozoites damage the intestinal per-
meability barrier, allowing the ﬂux of ﬂuoresceinated dextran
from the lumen of colonic xenograft into the circulation of the
SCID-HU-INT mice. Uninfected human intestinal xenografts
retain their permeability barrier, preventing the ﬂow of ﬂuo-
resceinated dextran into the circulatory system of the SCID-
HU-INT mouse. Human intestinal xenografts infected with
E. histolytica AP-A() trophozoites or the parental E. histo-
lytica HM1:IMSS strain both showed damage to the intestinal
permeability barrier, with detection of ﬂuoresceinated dextran
in the serum of the SCID-HU-INT mice (Fig. 3D). Levels of
ﬂuoresceinated dextran were signiﬁcantly higher in human in-
testinal xenografts infected with the parental HM1:IMSS strain
or the AP-A() E. histolytica trophozoites compared to unin-
fected human colonic xenografts (P 	 0.01 for each compari-
son [two-tailed t test]). Although serum levels of FITC-dex
were lower in SCID-HU-INT mice with colonic xenografts
infected with AP-A() E. histolytica trophozoites compared to
serum obtained from SCID-HU-INT mice with human colonic
xenografts infected with the parental HM1:IMSS strain, this
FIG. 1. AP-A() E. histolytica trophozoites produce little detect-
able AP-A by immunoblotting. Lysates from AP-A() E. histolytica
trophozoites [AP()] or the parental E. histolytica HM1:IMSS strain
(control) were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and reacted with a polyclonal antiserum to AP-A. A
prominent band at 5 kDa (the region where amoebapores migrate)
is visible in the control lane but is barely detectable in the lane loaded
with lysates from AP-A() trophozoites.
FIG. 2. AP-A() E. histolytica trophozoites cause signiﬁcantly
smaller amebic liver abscesses compared to the parental HM1:IMSS
strain in SCID mice. The mean percentage of liver abscessed from
SCID mice (n  13) infected with AP-A() E. histolytica trophozoites
[AP()] or SCID mice (n  13) infected with the parental E. histo-
lytica HM1:IMSS strain (control) is shown. The standard deviation of
each mean value is shown in the error bars. The difference in the mean
percentage of liver abscessed between livers infected with AP-A()
trophozoites compared to the parental HM1:IMSS strain was signiﬁ-
cant at P 	 0.05 as determined by a two-tailed Student t test.
680 ZHANG ET AL. INFECT.I MMUN.difference was not statistically signiﬁcant (P  0.24 [two-tailed
Student t test]). Histologic examination of microscopic sections
did not reveal differences between sections obtained from hu-
man intestinal xenografts infected with AP-A() E. histolytica
trophozoites and those infected with the parental HM1:IMSS
strain (data not shown).
DISCUSSION
The use of genetic approaches (dominant-negative mutants,
antisense expression) has facilitated the effort to deﬁne viru-
lence factors of E. histolytica (16). Key roles for the amebic
Gal/GalNAc speciﬁc lectin (21), amebic cysteine proteinases
(3), and amoebapores (5) in the formation of amebic liver
abscesses in gerbil or hamster models have been established
through these approaches. One limitation of the current ge-
netic approaches using antisense to reduce the expression of a
targeted E. histolytica gene is the inability to completely block
gene expression. In the case of amebic cysteine proteinases,
residual proteinase activity of 10 to 20% of wild-type levels was
found in amebic trophozoites expressing the antisense con-
struct, (22). Similarly, amebic trophozoites expressing an anti-
sense construct to the E. histolytica alcohol dehydrogenase 2
(EhADH2) gene had residual alcohol dehydrogenase that was
FIG. 3. Comparison of amebic colitis in human colonic xenografts obtained from SCID-HU-INT mice after xenograft infection with either
AP-A() E. histolytica trophozoites or the parental E. histolytica HM1:IMSS strain. In all panels, values are the mean  the standard deviation
for 15 human colonic xenografts infected with AP-A() E. histolytica trophozoites [AP-A()], or 15 human colonic xenografts infected with the
parental E. histolytica HM1:IMSS strain (control) or ﬁve uninfected human colonic xenografts (uninfected). Shown are values for IL-1, expressed
as picograms of IL-1 per milligram of total protein (A); IL-8, expressed as picograms of IL-8 per microgram of total protein (B); MPO, expressed
as MPO per milligram of total protein (C); or the levels of FITC-dex in the serum of the host SCID-HU-INT mice, expressed as nanograms of
FITC-dex/ml/mm
2 (D).
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pression of AP-A gene could be silenced by transfection with a
plasmid expressing the gene and its regulatory elements, pro-
vides a new tool for analyzing the role of AP-A in disease (6).
However, while essentially free of AP-A, these trophozoites
may not be completely free of amoebapore activity, since we
found that they still express transcripts for one of the isoforms,
AP-C. This isoform only accounts for ca. 3% of the total
amoebapore content (13) but is reported to have the highest
ion pore-forming activity (11).
Previous studies with AP-A() trophozoites showed that
AP-A expression was required for amebic liver abscess forma-
tion in hamsters, since no hamsters inoculated with AP-A()
trophozoites developed amebic liver abscesses (6). In the
present study we examined whether a similar effect could be
seen in the SCID mouse model of amebic liver abscess. Our
results conﬁrmed the decreased virulence of AP-A () tro-
phozoites, since liver abscesses were signiﬁcantly smaller in
SCID mice challenged with AP-A() trophozoites. However,
unlike experiments in hamsters, the difference was not abso-
lute, since most SCID mice challenged with AP-A() tropho-
zoites still developed amebic liver abscesses. This may reﬂect
an increased susceptibility of SCID mice to amebic liver ab-
scesses, the different timing of liver abscess assessment in each
model (48 h in the SCID mouse model versus 7 days in ham-
sters), or possible differences in the role of the amoebapore in
each animal model.
Of greater interest was whether AP-A() trophozoites
would show decreased virulence in the SCID-HU-INT model
of amebic colitis. This model, which allows one to study the
interaction of E. histolytica trophozoites and human colon in
vivo, has proven useful for analyzing both host responses to
infection and the role of speciﬁc E. histolytica molecules in the
pathophysiology of amebic colitis (14, 15, 20, 22). Previous
studies have established that infection of human colonic xeno-
grafts with E. histolytica trophozoites results in the activation of
epithelial cell NF-B, with production of inﬂammatory medi-
ators, including IL-1, IL-8, tumor necrosis factor alpha, and
COX-2, and the resultant inﬂux of neutrophils and other in-
ﬂammatory cells into the mucosa and lumen of the human
colonic xenograft (15, 20, 23). The combination of mucosal
invasion by E. histolytica trophozoites and the resultant inﬂam-
matory response leads to intestinal mucosal damage with ul-
ceration and loss of the intestinal permeability barrier (15, 23).
The AP-A() phenotype in the SCID-HU-INT model of
amebic colitis proved complex. All parameters associated with
infection (cytokine production, neutrophil inﬂux, and damage
to the permeability barrier) were signiﬁcantly higher in human
colonic xenografts infected with AP-A() trophozoites than in
uninfected human colonic xenografts, indicating that the fail-
ure to express AP-A does not render E. histolytica trophozoites
avirulent. However, compared to the parental HM1:IMSS
strain, we found that AP-A() trophozoites induced signiﬁ-
cantly lower levels of human IL-1 and IL-8 from human
colonic xenografts. Thus, in one component of infection (in-
duction of human cytokine production from intestinal epithe-
lial cells) AP-A() trophozoites are clearly less efﬁcient than
the parental HM1:IMSS strain. We and others have previously
hypothesized that E. histolytica lysis of intestinal cells might
result in the release of preformed mediators (e.g., IL-1) (8) or
cytokine precursors (pIL-1), which could initiate the inﬂam-
matory response (15). The reduced levels of these cytokines in
colonic xenografts infected with E. histolytica AP-A() tropho-
zoites is consistent with some role for amoebapore-mediated
intestinal cell lysis in the higher cytokine levels seen with E.
histolytica colonic infection.
Since both IL-1 and IL-8 are potent inﬂammatory media-
tors, one might predict that the decreased levels of each of
these cytokines seen in human colonic xenografts infected with
AP-A() trophozoites would be associated with lower tissue
levels of MPO, a marker for neutrophil inﬂux into the infected
xenograft. Levels of MPO were lower in human colonic xeno-
grafts infected with AP-A() trophozoites than in colonic
xenografts infected with the parental HM1:IMSS strain, but
this difference was not statistically signiﬁcant. This may reﬂect
the fact that the levels of IL-1 and IL-8, although reduced,
were still above the threshold needed to induce inﬂammatory
responses. Alternatively, the levels of crucial mediators and
cytokines other than IL-1 and IL-8 may not be reduced in
human colonic xenografts infected with AP-A() trophozo-
ites. There was also a trend toward less damage to the intes-
tinal permeability barrier in human colonic xenografts infected
with AP-A() trophozoites compared to the parental HM1:
IMSS strain, but again this difference did not reach statistical
signiﬁcance. These results, along with the histologic ﬁndings,
which were essentially indistinguishable between human co-
lonic xenografts infected with AP-A() trophozoites com-
pared to those infected with the parental strain, indicate that
E. histolytica trophozoites that do not express AP-A(), show
relatively little attenuation of virulence in the SCID-HU-INT
model of colitis. These results contrast with our ﬁndings on the
role of E. histolytica cysteine proteinases in amebic colitis,
where proteinase-deﬁcient amebas showed defects in their
ability to invade into the intestinal mucosa and induced signif-
icantly less inﬂammation and tissue damage than the control
parental strain (22).
In summary, amoebapores produced by E. histolytica tropho-
zoites play a critical role in the formation of amebic liver
abscess in the SCID mouse model of disease Our results link
amoebapores to E. histolytica induction of intestinal epithelial
cell cytokine production but show that trophozoites lacking
AP-A expression can still cause inﬂammation and tissue dam-
age in the SCID-HU-INT mode of amebic colitis. In addition
to demonstrating that amoebapores may not be necessary in
the pathogenesis of amebic colitis, these data are also consis-
tent with the concept that tissue damage in amebic liver ab-
scess may develop through pathways different than those ob-
served in amebic colitis (17).
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